DSIP: sleep recordings and hormone assays
The hormone assay is oddly precise. The sleep evidence is harder to pin down. DSIP’s physiological role still eludes me.
The ACTH immunoassay
The ACTH experiment in men gave DSIP intravenously and found a reduction in plasma ACTH-like immunoreactivity lasting at least three hours. Plasma means the liquid part of blood. Cortisol remained unaffected and followed its normal daily decline.
That “like” in ACTH-like immunoreactivity deserves its space. It identifies an antibody-based measurement; treating it as a complete account of stress physiology gives the result a reach the experiment never established. I expected cortisol to supply the accompanying evidence. Instead, its ordinary daily pattern survived.
The ACTH–cortisol separation has me wanting a much better physiological explanation. The observed blood signal is a starting point, with the explanation still unfinished. It also leaves sleep quality and subjective calm unmeasured.
Six adults with disturbed sleep
A 1981 controlled experiment in six middle-aged adults with chronic insomnia tested synthetic DSIP given intravenously. Sleep lasted longer, interruptions were fewer and REM sleep increased slightly. REM is the sleep phase associated with dreaming. The sleep-promoting effect appeared in the second hour, and the study reported no daytime sedation.
I take this sleep observation seriously because the researchers observed sleep itself. Its small size and age leave me far from certain. A modern, larger replication would carry much more weight than another confident retelling of the same experiment.
The 2006 review of the sleep hypothesis judged the evidence for ordinary DSIP weak and poorly characterised. The clearest sleep-promoting effects often came from altered versions of the molecule. That review makes the encouraging early human observation harder to treat as a settled answer.
The modified peptide in mice
In a 2024 experiment in mice with drug-induced insomnia, researchers joined DSIP to another peptide intended to help it cross the blood-brain barrier. The fusion peptide reduced average daily wakefulness from roughly 720 to 500 minutes, a 31% reduction, and outperformed unmodified DSIP in that model.
Melatonin, serotonin and dopamine moved toward normal levels. Behavioural tests suggested less anxiety-like and depression-like behaviour, and hippocampal neuron density increased. These observations concern the fusion peptide in mice. The hippocampus is a brain region involved in memory; neuron density describes how many nerve cells occupy a given amount of tissue.
The DSIP fusion’s deliberate redesign intrigues me. A successful alteration can point toward a useful research problem, while ordinary DSIP still needs its own human evidence. The named sleep peptide and the engineered fusion deserve separate conclusions.
Origins and other experiments
DSIP was first isolated from blood leaving rabbits' brains during electrically induced sleep. Its name, delta sleep-inducing peptide, refers to slow-wave brain activity. The review of its proposed natural role describes the continuing difficulty of identifying a specific receptor, gene or precursor protein.
A separate experiment in female SHR mice used a preparation containing DSIP and reported changes in lifespan, spontaneous tumours and bone-marrow chromosome damage. That was a mixture tested in mice. I shelve that mixture’s tumour findings separately from its sleep claims: neither the preparation nor the outcome matches an ordinary DSIP insomnia claim.
DSIP accounts and risks
Online accounts describe easier sleep, deeper-feeling rest and vivid dreams. Others describe no effect, heavy mornings, headache, nausea or dizziness. These are anecdotal accounts, not clinical evidence; their disagreement cannot supply a reliable response rate.
DSIP has no medicine approval, including under the name Emideltide. Long-term human safety, interactions with sedatives, sleep medicines or alcohol, and safety during pregnancy or breastfeeding remain unestablished. The mechanism itself remains unresolved. Personal sleep problems need an assessment of their cause; these experiments supply no tested instructions for self-treatment.